Thyroid Disorders in India: A Complete Guide to Diagnosis, Treatment &

The Scale of Thyroid Disease in India

An estimated 42 million Indians suffer from thyroid disorders, making it one of the most common endocrine conditions in the country. Hypothyroidism — an underactive thyroid producing insufficient thyroid hormone — is the most prevalent, affecting women at a rate five to eight times higher than men. Iodine deficiency, autoimmune thyroid disease (Hashimoto's thyroiditis), and post-surgical hypothyroidism are the leading causes.

Hyperthyroidism, thyroid nodules, and thyroid cancer, while less common, represent significant clinical challenges requiring specialist management and specific pharmacotherapy. The overlap of thyroid symptoms with other conditions — fatigue, weight changes, mood disorders — frequently leads to delayed diagnosis.

Hypothyroidism: Pharmacological Management

Levothyroxine (L-T4): The Standard of Care

Levothyroxine (synthetic T4) is the treatment of choice for hypothyroidism. It is converted to the active T3 form peripherally, mimicking normal thyroid physiology. Consistent, lifelong daily dosing is required for most patients with permanent hypothyroidism.

Key prescribing considerations include: taking Levothyroxine on an empty stomach 30–60 minutes before food for optimal absorption; avoiding concurrent administration with calcium, iron supplements, antacids, and certain foods (soya, high-fibre) that reduce absorption; and monitoring TSH levels 6–8 weeks after any dose change.

Special Populations

Hypothyroidism in pregnancy requires aggressive treatment to TSH targets below 2.5 mIU/L in the first trimester, as maternal thyroid hormone is critical for foetal neurological development. Dose requirements typically increase 25–50% during pregnancy. Congenital hypothyroidism requires immediate treatment within the first weeks of life to prevent irreversible intellectual disability.

Hyperthyroidism: Medical Management

Antithyroid Drugs

Carbimazole and Propylthiouracil (PTU) are the primary antithyroid drugs used in India. They reduce thyroid hormone synthesis by blocking thyroid peroxidase enzyme activity. Carbimazole is preferred for most patients; PTU is preferred in the first trimester of pregnancy and in thyroid storm due to its additional peripheral T4-to-T3 conversion blocking effect.

Both agents carry the risk of agranulocytosis — a potentially life-threatening reduction in neutrophil count occurring in 0.1–0.5% of patients. Patients must be counselled to report sore throat, fever, or mouth ulcers immediately, and treatment must be stopped pending urgent white cell count.

Beta-Blockers in Hyperthyroidism

Propranolol and Atenolol are used as adjunctive therapy to rapidly control adrenergic symptoms of hyperthyroidism — palpitations, tremor, anxiety, and tachycardia — while awaiting the slower onset of antithyroid drug effect.

Thyroid Cancer: Radioactive Iodine and Levothyroxine Suppression

Following surgical thyroidectomy for differentiated thyroid cancer, patients require Levothyroxine at TSH-suppressive doses to inhibit residual thyroid cancer cell growth (TSH stimulates thyroid cell proliferation). Radioactive iodine (I-131) ablation destroys residual thyroid tissue. Long-term Levothyroxine therapy at doses maintaining TSH below the normal range is the cornerstone of post-surgical thyroid cancer management.

Iodine Deficiency: A Preventable Cause of Hypothyroidism

Iodine deficiency was historically the most common cause of hypothyroidism globally, causing goitre, cretinism, and cognitive impairment. The Universal Salt Iodisation programme has dramatically reduced iodine deficiency in India, but pockets of deficiency persist in hilly regions of the Himalayas, sub-Himalayan zones, and the Deccan Plateau. Ensuring adequate iodine intake through iodised salt remains a public health priority.

Thyroid Screening: Closing the Diagnosis Gap

Given the high prevalence and significant proportion of undiagnosed thyroid disease in India, systematic screening of high-risk groups is recommended: women planning pregnancy or in the first trimester, patients with family history of autoimmune thyroid disease, individuals with unexplained fatigue or weight changes, and patients on thyroid-affecting medications (lithium, amiodarone, interferon).

Kasdap Healthcare and Endocrine Health

Kasdap Healthcare's product portfolio includes thyroid management medicines and endocrine health products — all sourced from WHO-GMP certified manufacturers to ensure the consistent potency that narrow therapeutic index medicines like Levothyroxine demand.